Conditions: Luteal Hormone Supplementation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 108
Healthy volunteers: no

Brief summary:
The purposes of the study are to verify sufficient supplementation of luteal hormone after administrating FE999913 Vaginal Tablet twice a day (BID) or three times a day (TID) and to determine the efficacy and safety of FE999913 Vaginal Tablet in Japanese women undergoing fertility treatment with IVF-ET (a fresh embryo transfer).

Detailed description:

Arms:
arm 1: FE 999913 100 mg vaginal tablet BID arm 2: FE 999913 100 mg vaginal tablet TID

Interventions: intervention 1: FE 999913 vaginal tablet
Intervention descriptions: intervention 1: None

Protocol document: